Deflazacort is a glucocorticoid used as an anti-inflammatory and immunosuppressant. It was patented in 1965 and approved for medical use in 1985. The U.S. Food and Drug Administration considers it to be a first-in-class medication for Duchenne muscular dystrophy.
Specification
Brand Name | Nr |
Manufacturer | Standard |
Packaging Size | Drum |
Packaging Type | Drum |
Product Type | Api |
Form | Powder |
Grade Standard | Standard |
Purity | 99 |